Detail Data
Volume (24h): 20,667 shares
P/E Ratio: /
Forward P/E: 6.61
EPS: -0.62 NZD
Forward EPS: 0.36 NZD
Number of Shares: 1,015,710,016 shares
Market Capitalization: 2,417,390,080.00 NZD

Dividend

Dividend Value
Dividend Amount According to our data, the company Ryman Healthcare does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: 2022-12-08
5-Year Avg Yield %: 2.05 %
Payout Ratio: -
Last Dividend Value: 0.120681 NZD
Last Dividend Date: 2022-06-01

Analyst Forecast

Most analysts have issued a buy recommendation for Ryman Healthcare stock. The current number of analysts covering this company is 4. The highest target price is 3.5 NZD, while the lowest target price is 2.5 NZD. The median target valuation set by analysts is 2.7 NZD. These forecasts and recommendations provide insight into how analysts view the future stock performance of Ryman Healthcare.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for Ryman Healthcare stock is: buy
Number of Analysts: 4
Highest Target Price: 3.5 NZD
Lowest Target Price: 2.5 NZD
Median Target Price: 2.7 NZD

Fundamental Indicators

Indicator Data
Total Revenue: 759,164,032.00 NZD
Net Income: -436,831,008.00 NZD
Price-to-Book (P/B): 0.57
PEG Ratio: /
Exchange: NZSE
Industry: Medical Care Facilities
Sector: Healthcare
Number of Employees: 7700
Country: New Zealand

Where to Buy Ryman Healthcare Stock?

You can purchase Ryman Healthcare stock on the NZSE under the ticker symbol: RYM.NZ. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Ryman Healthcare Stock

Indicator Value
Company Revenue: 759,164,032.00 NZD
EBITDA: -5,397,000.00 NZD - Negative EBITDA may signal financial challenges or growth investments.
Earnings Per Share: -0.62 NZD
Book Value Per Share: 4.20 NZD
Total Cash: 19,043,000.00 NZD
Total Cash per Share: 0.02 NZD
Total Debt: 1,710,604,032.00 NZD
Debt to Equity Ratio: 0.40
Quick Ratio 0.01
Current Ratio 0.04
Free Cash Flow 300,384,992.00 NZD
Operating Cash Flow 410,249,984.00 NZD
Gross Margins 1.06 %
EBITDA Margins -0.71 %
Operating Margins -9.73 %
Profit Margins -57.54 %
Return on Assets -0.2 %
Return on Equity -10.9 %
Earnings Growth (1 year) -
Revenue Growth (1 year) 10.9 %
Quarterly Earnings Year-over-Year Growth -
Market Capitalization 2,417,390,080.00 NZD
Enterprise Value 3,964,134,656.00 NZD
EV/Revenue 5.222
EV/EBITDA -734.507
Float Shares 987,057,857 shares
Shares Outstanding 1,015,710,016 shares
Held Percent Insiders 0.14 %
Held Percent Institutions 25.74 %
Shares Short -
Shares Short Prior Month -
Date Short Interest -
Short Percentage of Total Shares -
Short Ratio -
Beta 0.30
Short Percentage of Float -
Implied Shares Outstanding 1,015,710,016

Frequently Asked Questions (FAQ)

According to our data, the company Ryman Healthcare does not pay dividends yet, even in 2025.

Ryman Healthcare shares are traded on the NZSE stock exchange under the ticker: RYM.NZ. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

According to our data, the recommendation for Ryman Healthcare shares is from a total of 4 analysts. The average target price prediction is 2.7 NZD per share.

The total number of Ryman Healthcare shares on the exchange is 1,015,710,016.00 shares, which at the current market capitalization gives the company a total valuation of 2,417,390,080.00 NZD.